Acne scar treatment with RF microneedling INFINI




CLICK HERE for the Acne No More program
#acne #acnetreatment #acnetips #acnecare

Dermatologist and cosmetic surgeon Dr. Melanie Palm of discusses and demonstrates the use of recently FDA-approved multipolar radiofrequency microneedling device INFINI by Lutronic. Dr. Palm is the first U.S. doctor to use this RF device. This combines the synergestic collagen building ability of both microneedling and radiofrequency. Unlike other devices, this allows RF energy to be delivered below the surface of the skin. Therefore, it is safer on tan skin and darker skin types without risking hyperpigmentation after the procedure. The procedure is comfortable and only requires topical numbing. The skin is slightly red after the procedure. There is little downtime with the procedure compared to traditional resurfacing procedures. For more information, call Art of Skin MD at 858.792.7546.

“Subscribe To “Dr. Melanie Palm” Channel HERE:
Watch a clinic tour of “Art of Skin MD by Dr. Melanie Palm” HERE:
Like “Art of Skin MD by Dr. Melanie Palm on Facebook HERE:
Follow “Dr. Melanie Palm at Art of Skin MD” on Twitter HERE:

Ready more about “Dr. Melanie Palm at Art of Skin MD” at her practice website,
Contact “Dr. Melanie Palm at Art of Skin MD” at her clinic phone number of 858.792.7546.


Dr. Melanie Palm is the founding director of Art of Skin MD, assistant clinical professor at the University of California, San Diego, and staff physician at Scripps Encinitas Memorial Hospital. Dr. Palm is a board-certified dermatologist and cosmetic surgeon offering a full-spectrum of medical and cosmetic dermatologic care and a frequent media contributor in the field of dermatology, aesthetic medicine, health and beauty. She specializes in cosmetic dermatologic surgery including injectable fillers, nonsurgical rejuvenation, laser and light technology, skin tightening, nonsurgical fat removal, liposuction, fat transfer, and sclerotherapy.


Leave a Reply

Your email address will not be published. Required fields are marked *

*